The Virginia Vascular Society welcomes abstracts for oral, case, and poster submissions.
Title: CERIB Technique for Internal Iliac Preservation and Short-term Outcomes in Patients with Aortoiliac Occlusive Disease
In 2009 Goverde et al., developed the Covered Endovascular Reconstruction of the Aortic Bifurcation (CERAB) technique as a new approach for extensive and/or recurrent AOD using three covered balloon expandable stents to reconstruct the aortic bifurcation1. Since then, CERAB has become a well-established alternative to Aortobifemoral Bypass for Aortoiliac Occlusive Disease (AIOD). Over this same time period preservation of Internal Iliac Arteries has become recommended in the setting of aneurysmal disease with commercialization of iliac branch endoprosthesis. It seems natural to want to preserve internal iliac artery patency in the setting of AIOD, as well. This case series discusses 6 patient cases who had the CERAB technique transferred to the level of the iliac bifurcation (the CERIB technique) to preserve internal iliac artery patency. We report our experience with these patients and their short-term outcomes.
We present six cases within a one-year period in which male patients (ages ranging from 61-70 years old) presented at the clinic with worsening bilateral lower extremity claudication. Patients all underwent CTAs and ABIs preoperatively. These patients then underwent the CERIB technique which consisted of a bilateral iliofemoral endarterectomy with kissing iliac stents using a combination of Gore VBX and Viabahn. There were no complications during or directly following the procedure.
Postoperatively, all patients had a near or complete resolution of their claudication and significant improvements in their ABIs. This case series illustrates a potentially new minimally invasive surgical approach to treating AIOD at the level of the iliac bifurcation that preserves the internal iliac artery. Future studies will explore the long-term differences in clinical improvement outcomes of this new surgical approach to AIOD when compared to the current gold standard methods.
Relevant test results:
Deadline is September 1, 2023
Submission & ACCME Policy
Authors are required to complete the conflict of interest section when submitting an abstract. Additionally, the submitting/corresponding author will now be asked the following two questions during the submission process:
• What professional practice gap does this abstract address?
• How will this abstract influence change in competence, performance or patient outcomes?
ACCME Policy on Employees of Commercial Interests
Industry employees can be authors, but cannot be presenters if the content of the abstract relates to the business lines and products of its employer.
We are no longer accepting new abstracts for this years meeting.